• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol Methods . Performance of RT-qPCR detection of SARS-CoV-2 in unextracted nasopharyngeal samples using the Seegene Allplex TM 2019-nCoV protoc

tetano

Editor, Senior Moderator
J Virol Methods


. 2021 Dec 14;300:114429.
doi: 10.1016/j.jviromet.2021.114429. Online ahead of print.
Performance of RT-qPCR detection of SARS-CoV-2 in unextracted nasopharyngeal samples using the Seegene Allplex [SUP]TM[/SUP] 2019-nCoV protocol


Flavia R O Barros[SUP] 1 [/SUP], Deborah C A Leite[SUP] 2 [/SUP], Larissa J Guimarães[SUP] 3 [/SUP], Juliana M H Lopes[SUP] 3 [/SUP], Marina W Vasconcelos[SUP] 3 [/SUP], Luciane X Ferreira[SUP] 3 [/SUP], Sandrieli Gonçalves[SUP] 3 [/SUP], Victor G F Pastre[SUP] 3 [/SUP], Gabriela Pereira[SUP] 3 [/SUP], Alex B Trentin[SUP] 3 [/SUP], Naiana C Gabiatti[SUP] 3 [/SUP], Betty C Kuhn[SUP] 3 [/SUP], Juliana M K C Perseguini[SUP] 3 [/SUP], Simone N Wendt[SUP] 3 [/SUP], Nédia C Ghisi[SUP] 4 [/SUP]



Affiliations

Abstract

The rapid spread of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led the world to a pandemic. Therefore, rapid, sensitive, and reproducible diagnostic tests are essential to indicate which measures should be taken during pandemics. We retrospectively tested unextracted nasopharyngeal samples from consecutive patients with suspected SARS-CoV-2 infection (n = 334), and compared two different Ct cut-off values for interpretation of results using a modified Allplex protocol. Its performance was evaluated using the USA Centers for Disease Control and Prevention (CDC) as reference. The reduction on Ct cut-off to 35 increased the test NPA from 79.65 to 88.00 %, reducing the number of false positives, from 10.48 to 6.29 %, resulting in an almost perfect agreement between the Allplex and the CDC protocol (Cohen's Kappa coefficient = 0.830 ± 0.032). This study demonstrates that the Seegene Allplex™ 2019-nCoV protocol skipping the viral RNA extraction step using the Ct cut-off of 35 is a rapid and efficient method to detect SARS-CoV-2 in nasopharyngeal samples.

Keywords: COVID-19; Coronavirus; Ct cut-off; Molecular diagnostics; Real time PCR.
 
Back
Top Bottom